Postpartum Hemorrhage (PPH) Devices Market Expected to Reach $1.3 Billion by 2030—Allied Market Research

According to a new report published by Allied Market Research, titled, “Postpartum Hemorrhage (PPH) Devices Market," The postpartum hemorrhage devices market size was valued at $797.32 million in 2020, and is estimated to reach $1.3 billion by 2030, growing at a CAGR of 5.3% from 2021 to 2030.

PPH is defined as the excess amount of blood loss (more than 500 ml) after the delivery of child from vagina, uterus, cervix, and perineum. Increase in incidence of pregnancy-related complications, including multiple pregnancies, inverted uterus, large baby size, surge in risk factors, which causes PPH, including uterine atony, trauma, retained placenta, and bleeding disorders, and technological advancements in the recently approved devices drive the postpartum hemorrhage devices market growth. However, lack of trained professionals and healthcare services in developing countries hampers the market growth.

The growth of the market is mainly driven due to the rise in incidence of postpartum hemorrhage cases. For instance, 300,000 women die each year worldwide during pregnancy or childbirth, with over 25% of these deaths from postpartum hemorrhage. This, highlights the demand for non-pneumatic anti-shock garment in PPH management and thereby leads to the expansion of market. 

In addition, non-pneumatic anti-shock garment has been adopted by United Nations International Children's Emergency Fund (UNICEF), United Nations Population Fund (UNFPA), NGOs, and governments, for the purpose of saving thousands of mothers’ lives and reducing the mortality rate. According to a report published by UNICEF in June 2022, NASG has been included in UNICEF's supply catalog, and it is receiving technical support and direction for its implementation, distribution, and procurement. Through this initiative along with UNICEF's, NASG can reach more women, ensuring reduction in PHH deaths in future.  

In addition, 11 countries are introducing NASG through UNICEF, to reduce the mortality rate associated with PPH. Thus, such initiatives taken by government and other private organizations for the betterment of the public, which creates awareness among the common people about the products, is driving the growth of the segment.Moreover, advantages such as reduction in blood flow and hypovolemic shock, ability to keep women alive for 48 hours, and providing assistance in transferring patient to healthcare facilities for treatment, fosters its demand in the market. In addition, lightweight, washable, and reusable nature of NAGS further propel its demand and lead to expansion of the market. 

The growing global expectation of the health and medical field leads to huge investment every year for the R&D activities to develop new drug delivery systems to ease the administration process. One such novel drug delivery system is the prefilled injection system, which is known for its least contamination and ease of administration. In addition, ease of administration, more convenient for healthcare professional & end user, easier in emerging situations, reduction of medication errors, mis-identification, and better dose accuracy are some factors leading to the adoption of prefilled injection systems, thereby leading to the market growth.  

For instance, Oxytocin in Uniject is an auto-disable pre-fillable injection system, which allows drug delivery system for intramuscular (IM) or subcutaneous injections used by the healthcare providers around the globe, for delivery of pre-filled drugs and protecting against inappropriate needle reuse. This prefilled injection system is used to treat postpartum hemorrhage and thereby reduces mortality rate related to pregnancy. Therefore, rise in incidence of PPH ultimately leads to increase in demand for prefilled injection system, thereby propelling the market growth.  

Postpartum hemorrhage devices industry is segmented on the basis of on product and region. Product segment is classified into non-pneumatic anti-shock garment, prefilled injection system, and uterine tamponade device. The uterine tamponade segment is further divided into foley catheter, condom catheter, balloon tamponade, and other. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Region-wise, North America dominated the postpartum hemorrhage devices market in 2020, and is expected to be dominant during the forecast period, owing to rise in the PPH cases and availability of advanced healthcare facilities. However, Asia-Pacific is expected to register highest CAGR of 6.4% from 2021 to 2030, owing to increase in rate of anemia among women in the region, which, in turn, increases the risk of postpartum hemorrhage. In addition, rise in awareness about PPH complications and increase in healthcare expenditure fuel the growth of global PPH device market.

KEY FINDINGS OF THE STUDY

• The study provides an in-depth postpartum hemorrhage devices market analysis, and the current trends & future estimations to elucidate imminent investment pockets.
• By product, the uterine balloon tamponade segment accounted for the largest postpartum hemorrhage devices market share in 2020.
• Region-wise, North America garnered the largest revenue share in 2020. However, Asia-Pacific is anticipated to grow at the highest CAGR during the postpartum hemorrhage devices market forecast.